1. Introduction

Digital Prescription Fraud Detection refers to the use of electronic systems, artificial intelligence (AI), machine-learning algorithms, pharmacy databases, electronic health records, and automated verification tools to identify potentially fraudulent, forged, altered, duplicated, or improperly issued medical prescriptions.

These systems are increasingly used by hospitals, pharmacies, insurance companies, telemedicine platforms, healthcare regulators, and pharmaceutical supply-chain operators.

However, an important legal problem arises when a legitimate digital prescription is incorrectly classified as fraudulent.

For example:

A genuine prescription is flagged as forged because the patient's identity does not match a database.

An AI system identifies a legitimate doctor's prescription as suspicious.

A pharmacy refuses to dispense essential medicine because an automated fraud score is unusually high.

An insurance company rejects a genuine medical claim based on an incorrect prescription-fraud alert.

A patient's medical record is incorrectly marked as fraudulent and shared with other healthcare institutions.

Such situations create the legal issue of false-positive liability.

False-positive liability concerns the responsibility of an organisation, healthcare professional, software developer, pharmacy, insurer, or digital platform when an automated fraud-detection system incorrectly identifies a lawful prescription as fraudulent and causes harm.

The central legal question is:

Who should bear responsibility when a technology designed to prevent prescription fraud wrongly accuses a legitimate patient, doctor, or pharmacist?

This issue involves medical negligence, consumer protection, privacy, administrative accountability, algorithmic discrimination, contractual liability, and constitutional rights.

2. Meaning and Nature of False-Positive Liability

A false positive occurs when a fraud-detection system identifies a legitimate transaction or prescription as suspicious or fraudulent.

For example, suppose a patient receives a genuine prescription for a controlled medicine from a licensed doctor. An automated system flags the prescription because the doctor's digital signature cannot be verified due to a temporary technical failure.

The pharmacy refuses the medicine, and the patient's medical condition deteriorates.

The resulting legal responsibility may arise from:

Negligent system design.

Inadequate algorithmic testing.

Failure to provide human review.

Incorrect or outdated medical databases.

Failure to correct inaccurate patient information.

Unreasonable refusal to dispense medicine.

Unlawful disclosure of fraud allegations.

Absence of an effective appeal mechanism.

Importantly, a false-positive result does not automatically establish liability. The claimant generally must establish an applicable legal duty, breach, causation, and legally recognised damage, subject to the relevant statutory framework.

3. Legal Framework in India

India does not currently have a dedicated statute dealing exclusively with liability arising from AI-based digital prescription fraud-detection errors. However, several existing laws provide relevant legal protection.

A. Constitution of India

Article 21 – Right to Life and Personal Liberty

Article 21 protects the right to life and personal liberty. Access to appropriate medical treatment and protection of personal dignity are important dimensions of this constitutional guarantee.

If a government hospital or public healthcare authority relies exclusively on an inaccurate automated fraud alert and denies essential medical treatment, constitutional questions may arise.

For example:

Wrongful classification of a genuine patient as a fraudster.

Unjustified denial of essential medication.

Discriminatory treatment based on inaccurate digital health records.

Failure to provide an effective review mechanism.

Article 14 – Equality Before Law

Article 14 prohibits arbitrary state action and unequal treatment.

If a government-operated prescription verification system disproportionately flags patients because of their location, disability, socioeconomic circumstances, or other irrelevant characteristics, its operation may be challenged on constitutional grounds.

However, an algorithmic error alone does not automatically establish an Article 14 violation. Arbitrariness, discrimination, or another constitutional defect must be demonstrated.

B. Consumer Protection Act, 2019

The Consumer Protection Act, 2019 is relevant where digital healthcare services, pharmacies, hospitals, or prescription-verification platforms provide services to consumers.

Important provisions include:

Section 2(11): Definition of deficiency in service.

Section 2(42): Definition of service.

Section 2(47): Unfair trade practices.

Section 35: Filing of consumer complaints.

Section 39: Relief available to consumers.

Section 82 onwards: Product liability framework.

A patient may potentially bring a consumer complaint where an organisation's negligent prescription-verification process causes denial of medical services, financial loss, or other compensable injury.

For instance, a pharmacy platform that repeatedly rejects authentic prescriptions because of an inadequately tested fraud-detection system may face a deficiency-in-service claim, depending on the facts.

C. Information Technology Act, 2000

The Information Technology Act, 2000 is relevant to electronic records, digital signatures, cybersecurity, and certain forms of computer-related misconduct.

Relevant provisions include:

Important qualification: Section 43A must be considered in light of the applicable commencement and repeal provisions of the Digital Personal Data Protection Act, 2023. It should not be treated as an indefinitely applicable independent remedy.

D. Digital Personal Data Protection Act, 2023

The Digital Personal Data Protection Act, 2023 is particularly important because prescription-verification systems process personal information relating to patients.

Such information may include:

Patient identity.

Medical history.

Prescription details.

Doctor identification.

Medication history.

Pharmacy transactions.

Digital authentication information.

The Act establishes a framework governing lawful processing, consent, security safeguards, and individual rights.

However, its commencement is phased. The November 2025 commencement notification provides for the principal data-processing obligations under Sections 3–17 to commence 18 months after publication, meaning they are not yet operative as of 6 November 2026.

E-Gazette+1

Therefore, it is important to distinguish between the Act's enactment and the commencement of its substantive obligations.

E. Drugs and Cosmetics Act, 1940 and Rules, 1945

The Drugs and Cosmetics Act and Rules regulate the manufacture, distribution, sale, and dispensing of medicines in India.

They are relevant where a prescription-fraud detection system prevents dispensing or permits the supply of medicines without appropriate legal verification.

A digital fraud-detection system cannot independently replace the statutory responsibilities of a pharmacist or other legally responsible professional.

F. Telemedicine Practice Guidelines, 2020

The Telemedicine Practice Guidelines, 2020 establish standards for remote medical consultations and prescribing.

They address:

Doctor-patient relationships.

Patient consent.

Prescription issuance.

Appropriate prescribing.

Medical record maintenance.

Privacy and security.

Professional responsibility.

The guidelines recognise the use of electronic prescriptions and digital transmission of prescriptions, subject to applicable safeguards and restrictions.

Ayush Portal+1

Consequently, an automated system should distinguish between a genuinely invalid prescription and a technically unverifiable but otherwise legitimate prescription.

4. Major Categories of False-Positive Liability

4.1 Liability of Hospitals

Hospitals may be responsible where their prescription-verification infrastructure is inadequately designed, negligently operated, or improperly supervised.

Examples include:

Failure to update doctor-registration databases.

Incorrect patient identity matching.

Inadequate verification of digital signatures.

Failure to provide manual verification.

Unreasonable refusal to dispense prescribed medicine.

Failure to maintain accurate medical records.

A hospital cannot necessarily escape responsibility by arguing that the decision was made by an algorithm purchased from an external technology company.

Where the hospital has an independent duty of care, delegation of technical functions does not automatically eliminate that duty.

4.2 Liability of Pharmacies

Pharmacies have professional and statutory responsibilities when dispensing medicines.

A pharmacy may face liability if it:

Blindly relies on an automated fraud score.

Fails to investigate an apparent technical error.

Rejects a genuine prescription without reasonable verification.

Falsely accuses a patient or doctor of prescription fraud.

Fails to follow applicable dispensing requirements.

However, a pharmacist is not automatically negligent for temporarily withholding a prescription that presents a genuine and reasonable safety concern.

The decisive question is whether the pharmacist acted reasonably in the circumstances.

4.3 Liability of AI Software Developers

Software developers may face civil or contractual liability where defective software causes foreseeable harm.

Examples include:

Incorrect algorithmic classification.

Defective identity-matching mechanisms.

Inadequate testing.

Unreliable prescription authentication.

Failure to correct known technical defects.

Misleading claims concerning the accuracy of fraud detection.

The developer's liability depends on its contractual obligations, applicable product-liability provisions, negligence principles, representations, and the causal connection between the defect and the injury.

4.4 Liability of Insurance Companies

Health insurers may use automated systems to detect suspicious prescriptions and fraudulent reimbursement claims.

A false-positive decision can result in:

Rejection of genuine medical claims.

Delayed reimbursement.

Incorrect blacklisting of patients.

Refusal of future insurance coverage.

Reputational damage.

An insurer may face contractual or consumer-law liability if it rejects a legitimate claim through an unreasonable or defective verification process.

A fraud indicator should not automatically be treated as conclusive proof of fraudulent conduct.

4.5 Liability of Telemedicine Platforms

Telemedicine platforms may be responsible for their own failures in prescription transmission, authentication, record management, or system security.

For example, a platform may incorrectly identify a valid doctor's digital signature as invalid because of a software update.

The platform's legal responsibility will depend on its actual role, contractual undertakings, applicable statutory obligations, and whether its conduct caused the patient's injury.

5. Detailed Case Laws and Judicial Principles

There is an important distinction between direct precedents and analogous judicial authorities: the following Indian decisions establish principles applicable to prescription-verification disputes, but they do not directly decide liability for AI-based prescription-fraud false positives.

Case 1. Jacob Mathew v. State of Punjab (2005) 6 SCC 1

Supreme Court of India

Facts:

The case concerned allegations of medical negligence following the death of a patient in a hospital. The allegations included failure to provide appropriate oxygen facilities and delays in medical assistance.

Legal issue:

What standard of negligence must be established before a medical professional can be held legally or criminally responsible?

Judgment:

The Supreme Court explained that professional negligence requires a breach of the standard of reasonable care and competence expected from a professional in the relevant circumstances.

It distinguished ordinary negligence from the higher threshold of gross negligence required for criminal liability against medical professionals.

Application to digital prescription fraud:

Suppose a hospital uses an automated prescription-verification system that incorrectly rejects a genuine prescription.

The following questions become relevant:

Was the system reasonably tested?

Did the hospital follow accepted professional standards?

Was human verification reasonably available?

Did the hospital ignore an obvious technical error?

Did the rejection cause actual injury?

A negligent system-management decision may support civil liability. However, criminal liability does not follow merely because the system produced an incorrect result.

Legal principle: A technical error does not automatically establish negligence; the applicable standard of care, breach, causation, and damage must be examined.

Indian Kanoon+1

Case 2. Indian Medical Association v. V.P. Shantha (1995) 6 SCC 651

Supreme Court of India

Facts:

The dispute concerned whether medical services provided by doctors and hospitals fell within the scope of consumer-protection legislation.

Legal issue:

Could patients seek consumer remedies for deficient medical services?

Judgment:

The Supreme Court recognised that medical services generally fall within the consumer-protection framework, subject to the applicable exceptions, including services rendered entirely free of charge to all patients and services under a contract of personal service.

Application to digital prescription fraud:

If a patient pays for a digital consultation or pharmacy service and the platform wrongly rejects a genuine prescription, the patient may potentially claim deficiency in service.

The case is important because digital healthcare is not automatically outside consumer-protection law merely because technology is involved.

Legal principle: Medical services can attract consumer liability when the legally applicable conditions are satisfied.

Case 3. Kusum Sharma v. Batra Hospital and Medical Research Centre (2010) 3 SCC 480

Facts:

The case concerned allegations of medical negligence and the standards applicable to professional medical conduct.

Legal issue:

How should courts determine whether professional conduct amounts to negligence?

Judgment:

The Supreme Court reaffirmed that negligence must be assessed by reference to the conduct of a reasonably competent professional.

An error of judgment is not necessarily negligence. The nature of the error and the circumstances in which it occurred must be considered.

Application to digital prescription fraud:

An automated system may sometimes generate an incorrect warning because of:

Incomplete information.

Database inconsistencies.

Technical authentication failures.

Unusual prescription formats.

The existence of a false-positive result alone does not prove negligence.

However, repeated failures, inadequate testing, ignored warnings, and absence of reasonable safeguards may demonstrate a breach of duty.

Legal principle: Professional liability depends on reasonable care and competence, not merely on an unsuccessful outcome.

Indian Kanoon+1

Case 4. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1

Facts:

The case concerned whether privacy is constitutionally protected under the Indian Constitution.

Legal issue:

Whether privacy constitutes a fundamental right.

Judgment:

The Supreme Court unanimously recognised privacy as a fundamental right protected under Article 21 and other freedoms in Part III of the Constitution.

Informational privacy was recognised as an important dimension of individual privacy.

Application to digital prescription fraud:

Suppose an AI platform incorrectly labels a patient as a prescription fraudster and shares the patient's prescription history with unrelated healthcare institutions.

This may raise questions concerning:

Unauthorised disclosure of medical information.

Excessive collection of personal data.

Unnecessary retention of fraud alerts.

Unjustified profiling.

Loss of informational autonomy.

The Puttaswamy judgment provides a constitutional foundation for examining such privacy intrusions, particularly where state action is involved.

Legal principle: Medical and personal information must be handled consistently with applicable privacy protections.

Indian Kanoon

Case 5. Maharaja Agrasen Hospital v. Master Rishabh Sharma (2020) 5 SCC 501

Facts:

The dispute concerned medical negligence and the failure to provide medical records within the prescribed period.

Legal issue:

Whether unreasonable delay in providing medical records could amount to professional misconduct and deficiency in service.

Judgment:

The Supreme Court addressed the importance of timely access to medical records and recognised the legal consequences of failing to comply with professional record-provision obligations.

Application to digital prescription fraud:

When a patient disputes an incorrect fraud alert, access to relevant records becomes important.

These may include:

Original electronic prescriptions.

Verification logs.

Doctor authentication records.

Rejection timestamps.

Audit trails.

Reasons for automated classification.

Failure to preserve or provide relevant records may create additional legal complications.

Legal principle: Medical documentation and access to records are important elements of healthcare accountability.

VoxJuris

6. International Legal Principles and Comparative Case Laws

Digital prescription fraud detection is also connected with international developments in algorithmic accountability and automated decision-making.

A. Bridges v. Chief Constable of South Wales Police [2020] EWCA Civ 1058

Facts:

The case concerned the use of automated facial-recognition technology by South Wales Police.

Legal issue:

Whether the use of automated identification technology complied with privacy and data-protection requirements.

Judgment:

The Court of Appeal found important defects in the legal framework and safeguards governing the deployment of the technology.

Application:

The case offers an analogy for digital prescription verification. Automated identification systems should operate within a sufficiently clear legal framework and with appropriate safeguards.

A prescription-verification platform should therefore have transparent verification procedures, defined operational limits, and mechanisms to correct inaccurate classifications.

B. SCHUFA Holding AG v. Verbraucherzentrale Bundesverband (Case C-634/21, 2023)

Facts:

The dispute concerned credit scoring and the use of automated scores in decisions affecting individuals.

Legal issue:

Whether an automated score could constitute automated decision-making under Article 22 of the GDPR when another organisation relied on that score.

Judgment:

The Court of Justice of the European Union held that automated credit scoring can fall within Article 22 where the recipient organisation relies on the score in a determining role.

Application:

Suppose a prescription-verification company assigns a patient a high fraud-risk score. A pharmacy automatically refuses the prescription because of that score.

The case provides an important comparative principle: an organisation cannot necessarily avoid automated-decision-making safeguards merely because another organisation formally communicates or implements the final decision.

This is particularly relevant where an AI vendor's fraud score effectively determines whether a patient receives medicine.

C. Dun & Bradstreet Austria GmbH v. Verein für Konsumenteninformation (Case C-203/22, 2025)

Legal issue:

The dispute concerned the right to meaningful information about automated decision-making under European data-protection law.

Judicial significance:

The Court addressed the requirement to provide meaningful information about the procedure and principles used in automated decision-making.

Application:

A patient challenging a prescription-fraud classification should, under an applicable legal framework, be able to obtain meaningful information about why the decision was made.

For example, a platform should be able to identify whether the rejection resulted from:

A failed digital signature.

An incorrect doctor's registration number.

A duplicate-prescription warning.

A patient identity mismatch.

A suspicious transaction pattern.

These comparative cases are not binding precedents in India, but they provide useful guidance for designing accountable automated healthcare systems.

7. Liability Under the GDPR: Comparative Legal Framework

The European Union's General Data Protection Regulation provides a particularly relevant framework for understanding false-positive liability.

Article 22 is especially relevant where a prescription-fraud decision is made solely through automated processing and produces legal or similarly significant effects.

Where the applicable conditions are satisfied, safeguards include human intervention, the opportunity to express one's position, and the right to contest the decision.

Legislation.gov.uk+1

For example, a European pharmacy platform should not simply assume that a high fraud-risk score conclusively establishes prescription fraud.

It must consider the relevant automated-decision safeguards and other applicable GDPR obligations.

8. Establishing Legal Liability: Essential Elements

A claimant alleging false-positive liability generally needs to establish the following elements, depending on the cause of action.

A. Duty of care

Hospitals, pharmacies, insurers, and technology providers may owe different duties depending on their functions.

A pharmacy's duty is not identical to the software developer's duty.

B. Breach of duty

A breach may occur where an organisation fails to maintain reasonable verification procedures.

Examples include:

Using outdated prescription databases.

Deploying untested fraud-detection models.

Ignoring known error rates.

Failing to introduce reasonable human review.

Failing to correct inaccurate records.

C. Causation

The claimant must establish that the wrongful classification materially caused the alleged injury.

For example, if a patient suffers a medical complication because essential medicine was wrongly withheld, medical evidence may be necessary to establish the causal relationship.

D. Damage

Potentially compensable damage may include:

Physical injury.

Additional medical expenses.

Financial loss.

Mental suffering where legally recognised.

Reputational injury.

Loss arising from unlawful disclosure of personal information.

The mere inconvenience of an incorrect automated alert does not automatically entitle someone to compensation.

9. Allocation of Liability Among Different Stakeholders

One of the most difficult legal questions is determining which participant should bear responsibility when multiple organisations contribute to a false-positive decision.

Liability is fact-specific. Several parties may potentially be responsible for different breaches, but responsibility cannot automatically be imposed on every participant.

10. Important Legal Defences

Organisations facing false-positive liability may raise several defences.

1. Reasonable technical precautions

The organisation may demonstrate that the system was appropriately tested, maintained, and monitored.

2. Genuine security concerns

A temporary refusal may be justified where there is a reasonable suspicion of forgery, tampering, or serious patient-safety risks.

3. Absence of causation

The defendant may establish that the alleged harm would have occurred independently of the automated classification.

4. Reasonable professional judgment

A healthcare professional may demonstrate that the decision was consistent with accepted professional standards.

5. Third-party misconduct

Evidence of deliberate forgery or unauthorised interference may be relevant, although third-party misconduct does not automatically absolve an organisation that independently breached its duty.

6. Absence of legally recognised damage

An incorrect flag without actionable injury or another recognised legal violation may not support a damages claim.

11. Remedies Available to Victims of False-Positive Prescription Detection

A patient, doctor, or pharmacist affected by an incorrect fraud classification may have different legal remedies depending on the nature of the violation.

A. Consumer remedies

A patient may approach the appropriate Consumer Commission under the Consumer Protection Act, 2019 where the dispute concerns deficiency in healthcare or digital services.

Potential remedies include:

Compensation for established loss.

Refund of service charges.

Correction of deficient services.

Appropriate directions against unfair trade practices.

B. Constitutional remedies

Where a government authority or public healthcare institution acts arbitrarily, an affected person may seek constitutional remedies under:

Article 32 before the Supreme Court, where a fundamental right is violated.

Article 226 before the appropriate High Court.

C. Civil remedies

Depending on the facts, a claimant may pursue civil proceedings for negligence, breach of contract, or other recognised legal wrongs.

D. Professional disciplinary proceedings

Where a registered medical practitioner is involved in professional misconduct, the appropriate medical regulatory authority may examine the complaint under applicable professional regulations.

E. Data-protection remedies

Where applicable data-protection obligations have commenced and are relevant, individuals may exercise statutory rights and pursue complaints through the prescribed regulatory mechanism.

F. Criminal remedies

Criminal proceedings may arise where the facts establish actual forgery, cheating, identity theft, unauthorised computer access, or other offences under applicable criminal legislation.

However, an accidental false-positive classification should not itself be treated as criminal conduct.

12. Preventive Measures and Algorithmic Accountability

Healthcare organisations should adopt a structured governance framework to reduce false-positive liability.

Particularly important safeguards

1. Human-in-the-loop verification

A high-risk prescription should be referred for qualified human review before a final adverse decision, particularly where essential treatment may be delayed.

2. False-positive monitoring

Organisations should regularly measure false-positive rates across different patient populations and prescription categories.

3. Explainability

The system should record the specific reason for flagging a prescription instead of merely producing an unexplained fraud score.

4. Right to correction

Patients and medical professionals should have an accessible process to correct inaccurate identity information and prescription records.

5. Emergency treatment protection

Fraud-prevention mechanisms should not create unnecessary delays in urgent medical treatment. Appropriate alternative verification procedures should be available.

13. Hypothetical Case Study

Consider the following situation:

A patient suffering from a serious medical condition receives a genuine electronic prescription from a registered medical practitioner.

The prescription is submitted to a pharmacy through a digital healthcare platform.

An AI fraud-detection system incorrectly identifies the prescription as forged because the doctor's registration information has not been updated in its database.

The pharmacy rejects the prescription.

The patient subsequently suffers a medical complication because the prescribed medicine is unavailable.

Legal analysis:

The hospital, pharmacy, platform, and technology provider may each face different legal questions.

A court would examine the contractual arrangements, applicable statutory duties, technical evidence, professional standards, and medical causation before determining liability.

14. Critical Legal Issues and Emerging Challenges

Digital prescription fraud detection creates several unresolved legal challenges.

A. Algorithmic opacity: Patients may be unable to understand why their genuine prescriptions were rejected.

B. Evidentiary difficulties: It may be difficult to obtain the algorithm's internal decision logs, training information, and error statistics.

C. Multi-party accountability: Hospitals, pharmacies, software developers, and insurers may blame one another.

D. Discriminatory outcomes: Incorrect fraud detection may disproportionately affect patients with unusual medical histories or incomplete digital records.

E. Medical emergency conflicts: Fraud prevention and timely access to essential medicines may come into conflict.

F. Reputational consequences: Incorrectly labelling a doctor or patient as fraudulent may cause professional or personal harm.

G. Automated decision-making: The increasing use of AI raises questions about meaningful human oversight and the legal responsibility of organisations relying on algorithmic decisions.

These challenges demonstrate the need for a healthcare-specific framework for algorithmic accountability.

15. Conclusion

Digital Prescription Fraud Detection False-Positive Liability represents an emerging intersection of healthcare law, artificial intelligence regulation, consumer protection, constitutional law, privacy, and professional negligence.

The primary legal concern is that systems developed to prevent prescription fraud should not themselves become instruments of unjustified denial of medical treatment.

Indian judicial principles established in Jacob Mathew, Indian Medical Association v. V.P. Shantha, Kusum Sharma, and Puttaswamy provide important foundations for determining professional responsibility, consumer remedies, reasonable care, and informational privacy.

International decisions such as SCHUFA and Bridges further demonstrate the importance of accountability and safeguards in automated decision-making.

The central legal principle is that automated fraud detection must remain subject to reasonable verification, human accountability, procedural fairness, and legally recognised remedies.

A healthcare organisation should not be permitted to treat an algorithmic fraud prediction as conclusive proof of wrongdoing. Equally, a software developer should not automatically be held liable merely because an algorithm produces an incorrect result.

Ultimately, liability should be determined by examining the duty of each participant, the reasonableness of the safeguards adopted, the nature of the error, and the actual harm caused.

16. Important Case Law Revision Table

Research note: None of the above Indian Supreme Court cases directly establishes a special cause of action for AI prescription-fraud false positives. Their principles must be applied to the particular facts and existing statutory remedies. The GDPR decisions are comparative European authorities, not binding Indian precedents.

The topic is particularly significant for future research on AI Healthcare Liability, Digital Medical Negligence, Algorithmic Consumer Protection, and Automated Medical Decision-Making Accountability.